Indianapolis, Indiana


Purpose:

The primary objective is to evaluate the analgesic efficacy of TRV130 for moderate to severe acute pain in patients presenting to the emergency department (ED) with a suspected/known, unilateral, closed long bone fracture.


Study summary:

This study is designed to evaluate the analgesic efficacy of TRV130 for the treatment of moderate to severe acute pain associated with a long bone fracture in patients presenting to the ED. The safety and tolerability of TRV130 will also be evaluated in this open-label pilot study.


Criteria:

Inclusion Criteria: - Age 18-65 years, inclusive - Has a suspected/known, unilateral, closed fracture of either: radius, ulna (or both) OR tibia, fibula (or both) BUT not fractures in more than 1 extremity - Able to understand and comply with study procedures and requirements, and provide written informed consent Exclusion Criteria: - Significant concomitant head, chest, or abdominal trauma - Multiple extremity trauma - Open fracture - Clinically significant medical condition or history of such condition that may place the patient at an unacceptable risk in the trial, may interfere with the interpretation of efficacy, safety, or tolerability data obtained in the trial, or may interfere with the absorption, distribution, metabolism, or excretion of drugs


NCT ID:

NCT02520297


Primary Contact:

Principal Investigator
Indiana University
Indiana University

Trevena
Phone: 610-354-8840
Email: clinicaltrials@trevenainc.com


Backup Contact:

N/A


Location Contact:

Indianapolis, Indiana
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.